Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2004 Jun 1;9(11):492-500.

Outsourcing lead optimisation--the quiet revolution.

Author information

1
Argenta Discovery, 8-9 Spire Green Centre, Flex Meadow, Harlow, Essex, UK CM19 5TR. david.clark@argentadiscovery.com

Abstract

The outsourcing of lead optimisation services is a relatively new but growing market. Historically, pharmaceutical companies have been hesitant to outsource activities at the lead optimisation stage of the drug discovery process, but more recently this reticence has largely been put aside. As a result, a growing number of companies with diverse backgrounds and geographical locations are now competing to offer services in this sector. Currently, a particularly significant trend is the move towards 'off-shoring', which promises to drive further changes in this rapidly evolving market in the near future.

Comment in

PMID:
15149625
DOI:
10.1016/S1359-6446(04)03102-2
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center